Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 2
1994 1
1995 1
1996 2
1997 2
1998 3
1999 1
2000 5
2001 1
2002 5
2003 6
2004 7
2005 9
2006 7
2007 6
2008 8
2009 12
2010 11
2011 8
2012 9
2013 8
2014 2
2015 9
2016 4
2017 2
2018 4
2019 9
2020 4
2021 6
2022 4
2023 5
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.
Monson KR, Ferguson R, Handzlik JE, Morales L, Xiong J, Chat V, Dagayev S, Khodadadi-Jamayran A, Simpson D, Kazlow E, Bunis A, Sreenivasaiah C, Ibrahim M, Voloshyna I, Ouwerkerk W, Luiten RM, Capone M, Madonna G, Lu Y, Shao Y, Pavlick A, Krogsgaard M, Mehnert J, Tang H, Dolfi S, Tenney D, Haanen JBAG, Gajewski TF, Hodi FS, Flaherty KT, Couts K, Robinson W, Puzanov I, Ernstoff MS, Rahma O, Postow M, Sullivan RJ, Luke JJ, Ascierto PA; IO-GEM Consortium; Osman I, Kirchhoff T. Monson KR, et al. Among authors: kirchhoff t. Nat Med. 2025 Jul;31(7):2385-2396. doi: 10.1038/s41591-025-03699-3. Epub 2025 Jun 5. Nat Med. 2025. PMID: 40473950 Free PMC article.
Skin cancer risk in BRCA1/2 mutation carriers.
Gumaste PV, Penn LA, Cymerman RM, Kirchhoff T, Polsky D, McLellan B. Gumaste PV, et al. Among authors: kirchhoff t. Br J Dermatol. 2015 Jun;172(6):1498-1506. doi: 10.1111/bjd.13626. Epub 2015 Apr 29. Br J Dermatol. 2015. PMID: 25524463 Free PMC article. Review.
Genome-wide association studies of cancer predisposition.
Stadler ZK, Vijai J, Thom P, Kirchhoff T, Hansen NA, Kauff ND, Robson M, Offit K. Stadler ZK, et al. Among authors: kirchhoff t. Hematol Oncol Clin North Am. 2010 Oct;24(5):973-96. doi: 10.1016/j.hoc.2010.06.009. Hematol Oncol Clin North Am. 2010. PMID: 20816582 Review.
Advances in the understanding and therapeutic manipulation of cancer immune responsiveness: a Society for Immunotherapy of Cancer (SITC) review.
Cesano A, Augustin R, Barrea L, Bedognetti D, Bruno TC, Carturan A, Hammer C, Ho WS, Kather JN, Kirchhoff T, Lu RO, McQuade J, Najjar YG, Pietrobon V, Ruella M, Shen R, Soldati L, Spencer C, Betof Warner A, Warren S, Ziv E, Marincola FM. Cesano A, et al. Among authors: kirchhoff t. J Immunother Cancer. 2025 Jan 16;13(1):e008876. doi: 10.1136/jitc-2024-008876. J Immunother Cancer. 2025. PMID: 39824527 Free PMC article. Review.
Germline determinants of clinical outcome of cutaneous melanoma.
Vogelsang M, Wilson M, Kirchhoff T. Vogelsang M, et al. Among authors: kirchhoff t. Pigment Cell Melanoma Res. 2016 Jan;29(1):15-26. doi: 10.1111/pcmr.12418. Epub 2015 Nov 3. Pigment Cell Melanoma Res. 2016. PMID: 26342156 Free PMC article. Review.
Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma.
Monson KR, Ferguson R, Handzlik JE, Xiong J, Dagayev S, Morales L, Chat V, Bunis A, Sreenivasaiah C, Dolfi S, Tenney DJ, Shao Y, Osman I, Weber JS, Kirchhoff T. Monson KR, et al. Among authors: kirchhoff t. Clin Cancer Res. 2024 Oct 1;30(19):4412-4423. doi: 10.1158/1078-0432.CCR-24-0900. Clin Cancer Res. 2024. PMID: 39115425 Free PMC article.
152 results